De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

T ScientificLtd Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

SangWoo Kim

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	0.1%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

Is T ScientificLtd (KOSDAQ:057680) A Risky Investment?

Oct 02

CEO

SangWoo Kim

no data

Tenure

SangWoo Kim serves as Chief Executive Officer of T Scientific Co.,Ltd.

T ScientificLtd Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Less than half of directors are independent

T Scientific Co., Ltd., Annual General Meeting, Mar 24, 2021

Recent updates

Is T ScientificLtd (KOSDAQ:057680) A Risky Investment?

New minor risk - Share price stability

New major risk - Financial position

T Scientific Co.,Ltd. announced that it has received KRW 2.99999997 billion in funding from WIZIT Co., Ltd.

T Scientific Co.,Ltd. announced that it expects to receive KRW 2.99999997 billion in funding from WIZIT Co., Ltd.

Full year 2023 earnings released: ₩737 loss per share (vs ₩210 loss in FY 2022)

T Scientific Co.,Ltd. announced that it has received KRW 5 billion in funding from FSN Co., Ltd.

T Scientific Co.,Ltd. announced that it expects to receive KRW 5 billion in funding from FSN Co., Ltd.

New minor risk - Market cap size

New minor risk - Share price stability

Less than half of directors are independent

T Scientific Co.,Ltd announced that it has received KRW 16 billion in funding from Daiduck Piping Co., Ltd.

T Scientific Co.,Ltd announced that it expects to receive KRW 4.99999914 billion in funding from WIZIT Co., Ltd.

Less than half of directors are independent

T Scientific Co.,Ltd announced that it has received KRW 30 billion in funding

T Scientific Co., Ltd., Annual General Meeting, Mar 24, 2021

T Scientific Co.,Ltd announced that it has received KRW 10 billion in funding from Swanicoco Co., Ltd.

T Scientific Co.,Ltd announced that it expects to receive KRW 10 billion in funding from Swanicoco Co., Ltd. and other investors

New 90-day low: ₩2,980

New 90-day low: ₩4,180

T Scientific Co.,Ltd (KOSDAQ:A057680) agreed to acquire additional 4.5% stake in TMD Lab for KRW 1.4 billion.

T Scientific Co.,Ltd announced that it has received KRW 5.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm

New 90-day high - ₩5,200

T Scientific Co.,Ltd announced that it expects to receive KRW 5.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm

CEO

Tenure